Swedish Orphan Biovitrum AB (publ)

kr 498.20As of Sun 8 Nov 2026, 12:00 UTC
STO:SOBIHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 18.83%
Div yield —
ROE 16.28%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.33
PE TTM 26.50
TSR TTM 52.26%
Mkt cap kr 173.4B
ROIC 13.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 594
19.20%
(44.64%)
Hold 1|7|1|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
5.87
6.16
6.29
6.94
12.52%
9.36%
15.53%
32.13%
Revenuekr B
8.268
8.662
8.823
8.993
0.93%
5.89%
10.94%
7.75%
Peers (US$17.53B)
Cap (US$)
PE
4.398B
58.11x
2.756B
259.4x
1.249B
31.56x
Capital
TTM
5Y
10Y
Leveragex
0.761
(0.206)
(0.161)
EBIT/Intx
1.790
0.120
0.116
Own earn%
276.50
31.68
49.73
Sh yield%
34.95
32.75
27.94
Owners
Insiders/Inst%
0.30
85.44
Short interest%
5.66
SBC / revenue%
1.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
22–25
$1 testx
−0.1
Incr. ROIC%
5